SCCM Resource Library-Year in Review Internal Medicine: Topic 1

Year in Review Internal Medicine: Topic 1

Video Transcription

Video Summary

Dr. Lokesh Dayal, a medical intensivist, discussed two landmark studies on community-acquired pneumonia (CAP). The first, CAPE-COD, explored the benefits of hydrocortisone in severe CAP, showing reduced 28-day mortality without significant risks of infection or GI bleeds, although requiring more insulin use. The second study, ACORN, compared cefepime and piperacillin-tazobactam for pseudomonal coverage, finding no significant differences in kidney outcomes, although cefepime was linked to higher delirium. These studies provide insights on treatment practices for severe CAP, particularly regarding corticosteroid use and antibiotic choice.

Asset Caption

Year in Review | Year in Review: Internal Medicine

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

community-acquired pneumonia

hydrocortisone

antibiotic choice

CAPE-COD study

ACORN study

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.